Patents Assigned to Pimera, Inc.
  • Crystal forms of a POL1 inhibitor
    Patent number: 11912706
    Abstract: The present invention relates to novel solid crystalline form of N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo [4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbaxomide, processes for the preparation thereof, compositions thereof and method of use thereof.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: February 27, 2024
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 11866438
    Abstract: Generally, the present invention provides novel quinolone and 5H-1,5,7,11b-tetraaza-benzo[c]fluoren-6-one compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: January 9, 2024
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 11623928
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: April 11, 2023
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 11618752
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: April 4, 2023
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 10975076
    Abstract: Generally, the present invention provides novel quinolone and 5H-1,5,7,11b-tetraaza-benzo[c]fluoren-6-one compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: April 13, 2021
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 10745403
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: August 18, 2020
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 10590134
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: March 17, 2020
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 10442801
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: October 15, 2019
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 9951066
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: April 24, 2018
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 9758518
    Abstract: Generally, the present invention provides novel quinoline compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: September 12, 2017
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Compositions, uses and methods for making them
    Patent number: 9512123
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: May 9, 2015
    Date of Patent: December 6, 2016
    Assignee: Pimera, Inc.
    Inventor: Mustapha Haddach